跳至主要内容
临床试验/ACTRN12615000950561
ACTRN12615000950561已完成4 期

A study to assess whether two different doses of antenatal intravenous iron administration (500 mg and 1000mg ferric carboxymaltose) are equivalent in replenishing and sustaining iron stores successfully in pregnant iron deficient women

yell McEwin Hospital0 个研究点目标入组 306 人开始时间: 2015年9月10日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
306

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
Female

入选标准

  • Pregnant women (2nd and 3rd trimester) with iron deficiency (serum ferritin <15mcg/mL) ; if elevated CRP then serum ferritin <50mcg/mL and TSAT <20%).

排除标准

  • 1.Patients with B12 pmol/L or folate nmol/L deficiency that cannot be corrected before trial entry will be excluded.
  • 2.Known hypersensitivity to ferric carboxymaltose or not eligible for dosing per approved Product Insert
  • 3.Haemoglobin (Hb) >130g/dL
  • 4.Hemochromatosis or other iron storage disorders
  • 5.Serious medical condition, uncontrolled systemic disease or any other medical condition (including an inability to fully comprehend and/or perform study procedures) that, in the judgment of the Investigator, prohibits the patient from entering or potentially completing the study

研究者

发起方
yell McEwin Hospital

相似试验

A study to assess whether two different doses of... | 临床试验